4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-18-005804
Options or other derivatives
- EVP, Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bell Graeme EVP, Chief Financial Officer | 2018-01-25 | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…